Year None2024202320222021202020192018 Sensei Biotherapeutics to Participate in Jefferies Global Healthcare Conference May 30, 2024 Read More Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-101 May 23, 2024 Read More Sensei Biotherapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights May 09, 2024 Read More Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ASCO Annual Meeting Apr 24, 2024 Read More Sensei Biotherapeutics to Participate in Canaccord Genuity’s Horizons in Oncology Virtual Conference Apr 09, 2024 Read More Sensei Biotherapeutics Announces Nature Communications Publication Describing Mechanism of Action of SNS-101 Selectively Targeting the Active Form of VISTA within the Tumor Microenvironment Apr 04, 2024 Read More Sensei Biotherapeutics to Participate in the 3rd Annual VISTA Symposium Mar 22, 2024 Read More Sensei Biotherapeutics to Present New Preclinical Data at Upcoming Scientific Conferences Mar 06, 2024 Read More Sensei Biotherapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights Feb 28, 2024 Read More Sensei Biotherapeutics to Present at Upcoming Conferences Feb 07, 2024 Read More Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 11